Introduction
Src family kinases, especially pp60 c-Src (c-Src), cooperate with receptor tyrosine kinases and components of the extracellular matrix to regulate normal cell growth and cell movement (Parsons and Parsons, 1997; Erpel and Courtneidge, 1995) . pp60 c-Src (c-Src) has been shown to associate directly with the platelet derived growth factor receptor (PDGFR) (Broome and Hunter, 1996) and CSF-1 receptor (Courtneidge et al., 1993) . Src was also reported to interact with EGFR (Sato et al., 1995; Stover et al., 1995) , and to phosphorylate the HER-2/ neu and IGF-1 receptors (Stover et al., 1995; Peterson et al., 1996) . In these cases, c-Src phosphorylates unique phosphorylation sites on these receptors that serve as docking sites for downstream signal transducers like p85, the regulatory subunit of PI 3'-kinase and Shc (Stover et al., 1995) . Thus, activation of Src may bypass the need for activation of growth factor receptors by growth factor.
The cooperation of Src family kinases with growth factor receptors also seems to play an important role in oncogenesis and tumor maintenance. Overexpression of EGFR or HER-2 in tumors correlates with increased cSrc kinase activity (Verbeek et al., 1996; Brunton et al., 1997; Ottenhol-Kal et al., 1992; Osherov and Levitzki, 1994) , and EGFR acts synergistically with c-Src to increase cell transformation and tumor invasiveness (Maa et al., 1995) . In addition, activation of the EGFR or HER-2/neu receptor in cell lines causes elevation in the activity of Src family kinases, and a direct correlation between the level of receptor expression and the level of Src kinase activity has been noted (Osherov and Levitzki, 1994) . Furthermore, in A431 cells, which overexpress EGFR and express the autocrine ligand TGFa ( Van de Vijver et al., 1991) , Src kinase was found to be persistently active (Osherov and Levitzki, 1994) . Similarly, NIH3T3 cells that overexpress HER-2 also possess persistently activated Src kinase (Levitzki, 1996) .
These ®ndings have suggested that Src plays a key role in tumorigenesis and should therefore be targeted for anti-cancer drugs (Levitzki, 1996) . To study this hypothesis further, we repressed c-Src expression with SRC antisense RNA. In addition, we also used a complementary approach in examining the role of Src in transformation by employing the selective Src family kinase inhibitor, PP1 (Hanke et al., 1996) . PP1 potently inhibits kinase activity without aecting Src protein levels, enabling us to examine the contribution of Src kinase activity to the transformed phenotype.
Results
Expression of SRC antisense reduces the levels of pp60 c-Src and induces growth inhibition and morphological changes Two cell lines were stably transfected with plasmids containing a fragment of c-Src cDNA in the antisense orientation into inducible systems (Gossen and Bujard, 1992 ) (see Materials and methods). This was to avoid inducing the expression of redundant Src family kinases such as Fyn and Yes, which appear to compete for c-Src substrates in c-SRC knockout systems (Imamoto et al., 1994) . Two cell lines were used: (i) DHER14 cells are NIH3T3 cells overexpressing EGFR in which pp60 c-Src is activated in the presence of EGF (Osherov and Levitzki, 1994) . DHER14 clones contain a fragment of the c-Src cDNA inserted into a Lac-Switch plasmid; SRC antisense RNA is expressed by exposure of cells to IPTG. (ii) CSH12 cells are NIH3T3 cells overexpressing the EGFR (out) -HER-2 (in) chimera, which possess high pp60 c-Src activity (Levitzki, 1996) . CSH12 clones contain a fragment of the c-Src cDNA inserted into a Tet-o-regulated plasmid, and SRC antisense RNA is expressed when cells are exposed to tetracycline-free medium.
Induction of the c-SRC antisense RNA in the DHER14 cell line inhibited the growth ( Figure 1A) , and reduced c-Src protein levels by 75% at 32 h ( Figure  1B ). In addition, the IPTG-treated cells adopted the morphology of quiescent cells, becoming large and¯at ( Figure 1C ), while the uninduced cells appear to have the morphology of transformed cells ( Figure 1D ). Furthermore, expression of c-SRC antisense RNA also reduced the ability of DHER14 cells to form colonies in soft agar (Figure 2 ). The number and size of colonies on soft agar decreased over 50% (Figure 2A ). Similar results were obtained with the selective inhibitor of Src kinase PP1 (Figure 2b and c; see also below).
c-Src inhibitor reduces Stat3 phosphorylation
Recent reports suggest that Stat3 is required for cellular transformation by Src (Bromberg et al., 1998; Turkson et al., 1998) . To examine the involvement of Stat3 tyrosine phosphorylation by Src (Yu et al., 1995) , we utilized speci®c anti-P-Y-Stat3 antibodies. In CSH 12 cells there is a signi®cant level of constitutive Stat3 phosphorylation ( Figure 3A ) as compared to DHER14 cells ( Figure 3C ). Application of PP1 decreased Stat3 tyrosine phosphorylation in both CSH12 and DHER14 in a dose dependent manner.
c-SRC antisense reduces Bcl-X L expression
To further investigate the eect of of c-SRC antisense RNA on Src-mediated signaling, we looked for changes in Bcl-X L , an anti-apoptotic protein, knowing that v-Src induces the expression of a newly discovered Bcl-2 family gene, NR-13, in avian cells (Gillet et al., 1995; Mangeney et al., 1996) . Induced expression of SRC antisense RNA resulted in a concomitant decline in the levels of Bcl-X L (Figure 4 ). The decline in Bcl-X L levels followed the decline in c-Src levels in both the DHER14 and the CSH12 cell lines expressing SRC antisense RNA. The decline in Bcl-X L expression in CSH12 and DHER14 cells ( In order to examine whether inhibiting Src activity is sucient for inducing the eects observed by reduction of the Src protein we employed the selective Src inhibitor PP1 (Hanke et al., 1996) . This inhibitor is a poor blocker of the EGF and IGF-1 receptors in cellfree systems as well as in cellular assays; PP1 does not inhibit signi®cantly the kinase activity of these receptors in intact cells up to 50 mM (Hanke et al., 1996 and our unpublished results) .
The application of PP1 to DHER14 cells severely reduced their ability to form colonies in soft agar in a dose dependent manner as depicted in Figure 2 (B and C) (IC 50 of 3 mM). Application of PP1 to DHER14 and CSH12 cells resulted in a decline in Bcl-X L levels in a dose dependent manner ( Figure 5 ). This eect of PP1 was speci®c, inasmuch as the levels of Erk-2 and Src were not aected ( Figure 5A ± C). These results are corroborated by the ®nding that the PP1 induced decline in Bcl-X L expression was followed by apoptosis ( Figure 6 ), as measured by Annexin-V binding ( Figure 6A , B and C) or DNA fragmentation (data not shown). Signi®cant apoptotic cell death was already noted at 5 mM PP1 ( Figure 6B and C) in both cell lines. No signi®cant necrosis was observed: cells were not stained by propidium iodide ( Figure 6A and B (d ± f)). Transfection of SRC antisense plasmid (pOPI3-CRS) into DHER14 cells also resulted in cell death, as compared to the empty vector (pOPI3). As a positive control, a similar plasmid coding for the pro-apoptotic protein HA-BAD was used ( Figure 6D ).
c-SRC antisense, kinase-dead c-Src, Src inhibitor and Stat3b reduce transcriptional activation of the Bcl-X promoter
We used two constructs, in which 3.7 kb upstream of the start of transcription (`full-length' promoter) or a shorter fragment of 0.6 kb (`short promoter') including six repeats of Stat3 binding sites (CatlettFalcone et al., 1999) , were tethered to a luciferase reporter gene. We examined transcription from the Bcl-X full-length promoter in transient co-transfections with c-SRC antisense plasmid (pOPI3-CRS), or in the presence of Src inhibitor PP1. As shown in Figure 7A , reporter expression was suppressed by c-SRC antisense and by PP1. We then examined transcription from the short promoter-luciferase construct. Figure 7B shows that the transient transfection of activated Src (Src F527) into CSH12 cells signi®cantly elevated the expression of the short fragment of Bcl-X promoter-reporter gene whereas the expression of the kinase-dead mutant Src reduced its expression even below control levels. The co-expression of Stat3b, the dominant negative form of Stat3 (Turkson et al., 1998) , strongly inhibited the expression of the Bcl-X reporter gene ( Figure 7B ). The selective Src inhibitor PP1 had a similar eect ( Figure 7C ).
Discussion
Elevated Src kinase activity has been shown in tumors that overexpress growth factor receptors, such as EGFR and HER-2 (Brunton et al., 1997; OttenholKal et al., 1992; Osherov and Levitzki, 1994; Maa et al., 1995) . We have shown previously that the level of Src kinase activity is proportional to the level of EGFR expression in DHER14 cells (Osherov and Levitzki, 1994) . Src kinase is constitutively active in A431 cells, which overexpress EGFR as well as its ligand TGFa ( Van de Vijver et al., 1991) . We have also shown that cells that overexpress Her-2/neu possess constitutive Src kinase activity (Osherov and Levitzki, 1994) .
In the present study we examined more directly the possible involvement of c-Src in the oncogenic phenotype of cells that overexpress the EGFR (DHER14 cells) and the HER1-2/neu chimeric receptor (CSH12). The decrease in c-Src levels after induction of c-SRC antisense RNA led to decreased levels of c-Src protein and growth inhibition of DHER14 cells (Figure 1 ). The morphological changes in DHER14 cells subsequent to antisense RNA These changes might point to the involvement of c-Src in adhesion signaling pathways (Sabe et al., 1997; McGill et al., 1997) . Growth in soft agar is a measure Figure 3 Src kinase inhibition reduces Stat3 tyrosine phosphorylation. DHER14 and CSH12 cells were seeded in 6 well plates (7610 4 cells/well) and after 24 h were treated with PP1 at the indicated concentrations for 4 h. DHER14 cells were activated with 20 nM EGF (10 min 378C) after the 4 h incubation with PP1. Cells were lyzed with sample buer and the lyzates were then run on SDS ± PAGE. The Western blot was probed with speci®c anti-P-Y-Stat3 (1 : 1000 dilution; New England Biolabs). As a control, the blots were probed with anti-Erk-2 (1 : 1000 dilution; Santa Cruz) or anti-Stat3 (1 : 1000 dilution; Transduction Laboratories). Stat3 tyrosine-phosphorylation levels were quanti®ed using the NIH-image program. . Cells were lyzed and after Western blotting probed with the monoclonal anti-Src antibody 327. The blots were also probed with polyclonal antibodies against Bcl-X L (1 : 1000 dilution; Transduction Laboratories). As a control, the blots of Lac Switch system clones were probed with anti-actin (1 : 2000 dilution; Santa Cruz). The blots of Tet clones were probed with anti-Erk-2 (1 : 1000 dilution; Santa Cruz). (B, C, E and F). c-Src, actin, Erk-2 and Bcl-X L levels were quanti®ed using the NIH-image program. Bcl-X L and c-Src levels were normalized to Erk-2 levels. At the 24 h time point (CSH12) less protein was applied to the gel which led to lesser amount of Erk-2. However, the amounts of Src and Bcl-X L were normalized to the amount of Erk-2. (A ± C). DHER14 cells.
of the ability of cells to grow without attachment to the substratum, which is typical of tumor cells. Colony formation in soft agar, which correlates with invasiveness, was also diminished after c-SRC antisense RNA induction or addition of Src speci®c inhibitor (Figure 3) . Thus, c-Src kinase seems to play an important role in the transformed phenotype of these cells. It has indeed been pointed out already that expression of v-Src confers upon cells the ability to grow in suspension and therefore may allow such cells to metastasize (Bromberg et al., 1998; Turkson et al., 1998; McGill et al., 1997) . We considered the possibility that activated Src may play a role not only in stimulating mitogenic pathways but also in elevating the anti-apoptotic robustness of the cancer cell. We found that a reduction in Src expression ( Figure 4A ± F) or Src kinase activity ( Figure 5 ) resulted in a concomitant decline in both the phosphorylation state of Stat3 (Figure 3 ) and the level of Bcl-X L protein ( Figure 5 ). This observation supports recent reports that activated Stat3 is required for cellular transformation by Src, and that Stat3-dependent Bcl-X regulation may be important in maintaining cell survival in cells in which Src is activated (Bromberg et al., 1998; Turkson et al., 1998; Catlett-Falcone et al., 1999) . Indeed it has been recently reported that v-Src induces the expression of a newly discovered Bcl-2 family gene, NR-13, in avian cells, and that this gene product acts as a potent anti-apoptotic agent (Gillet et al., 1995; Mangeney et al., 1996) . As expected, the decline in Bcl-X L expression was followed by induction of programmed cell death, as depicted in Figure 6 . CSH12 cells were more sensitive than DHER14 cells to Src inhibition, with faster induction of apoptosis already at 24 h (data not shown). This sensitivity may re¯ect the contribution of Src activation by the HER-2 receptor to cell survival in CSH12 cells. Since expression of v-Src in NIH3T3 cells constitutively Figure 5 Inhibition of Src kinase activity correlates with a decrease in Bcl-X L levels. CSH12 (A and B) and DHER14 cells (C ± F) were grown in 6 well plates (Nunc) in the presence of PP1 at the indicated concentrations for 24 (A and D) or 48 h (E and F). Cells were lyzed with sample buer and the lysates were then run on SDS ± PAGE. The Western blot was probed with speci®c antibodies and the c-Src, Erk-2 and Bcl-X L levels were quanti®ed using the NIH-image program. Bcl-X L levels were normalized to Erk-2 levels. The data shown is representative of at least two experiments Inhibition of pp60 c-Src reduces Bcl-x L expression R Karni et al activates Stat3 and induces Stat3-dependent transcription (Turkson et al., 1998) , and the Bcl-X L promoter possesses putative Stat3 binding sites (Catlett-Falcone et al., 1999), we examined the possible involvement of c-Src in the regulation of transcription from the Bcl-X promoter. We found that application of the Src kinase inhibitor PP1 or transfection of SRC anti-sense plasmid inhibits luciferase production from a Bcl-X promoterluciferase construct (Figure 7) . Transfection of activated Src (Src F527) to CSH12 cells elevated the expression of a Bcl-X reporter gene whereas the expression of the kinase-dead mutant Src reduced its expression even below control levels. Coexpression of the dominant negative form of Stat3 profoundly inhibited the expression from the Bcl-X reporter gene ( Figure 7B ). These data suggest that Stat3 mediates c-Src dependent Bcl-X L transcription. Furthermore, PP1 treatment leads to inhibition of Stat3 phosphorylation, which is the primary mechanism of Stat3 activation (Turkson et al., 1998; Yu et al., 1995) . The activation and association of Stat3 with v-Src has already been established in a number of systems (Turkson et al., 1998; Yu et al., 1995; Cao et al., 1996) . It seems therefore that Stat3 is an important mediator of Src-dependent Bcl-X L expression. Our observations suggest that receptor tyrosine kinases can activate anti-apoptotic pathways through activation of Src, which in turn induce elevation of Bcl-X L expression. One such receptor may be the CSF-1 receptor which is known to activate c-Src (Courtneidge et al., 1993) , and to activate Stat3 (Cao et al., 1996) . This conclusion does not negate the possibility of direct phosphorylation of Stat3 by growth factor receptors (Fu and Zhang, 1993) . Another possible mechanism by which Src activity may confer anti-apoptotic robustness to the cancer cell is by its interaction with receptors that transduce antiapoptotic signals. For example, it has been shown that activation of cells with IGF-1 rapidly induces the expression of Bcl-X L (Parrizas and LeRoith, 1997) , and that c-Src phosphorylates the IGF-1 receptor, leading to receptor activation even in the absence of IGF-1 (Peterson et al., 1996) . Thus, Src may induce Bcl-X L expression via IGF-1R. The observation that cells lacking IGF-1R could not be transformed by Src (Peterson et al., 1996) supports the existence of such a pathway. It is also possible that c-Src may mediate crosstalk between other growth factor receptors and the IGF-1 receptor, thus driving an anti-apoptotic signal in the absence of IGF-1.
In summary, our results support the hypothesis (Levitzki, 1996) that c-Src is a major signaling element in the transformation machinery of cells that express the EGFR family receptors at high levels. Src seems to function as an anti-apoptotic element through the positive regulation of Bcl-X L expression, thus elevating the oncogenic robustness of the transformed cell. These results strengthen the hypothesis that Src family , should be targeted for the development of anti-cancer agents that may show ecacy in a wide range of malignancies.
Materials and methods
Cell culture DHER14 cells were grown in Dulbecco's modi®ed Eagles medium (DMEM) supplemented with 10% calf serum (CS). CSH12 cells were grown in DMEM supplemented with 10% fetal calf serum (FCS). All media were supplemented with penicillin and streptomycin. For routine growth of clones, antibiotic selection was maintained. All experiments were performed in the absence of antibiotic selection. Transcription from the Lac Switch plasmid pOPI3-CRS was induced by adding 5 mM isopropyl-b-D-thio-galactopyranoside (IPTG). Transcription from the tTA-regulated plasmid pNRTIS-CRS was induced by replacing the medium with a doxicyclin free medium.
c-SRC antisense mRNA-construction of plasmids
For the Lac Switch system (Stratagene) a 175 bp fragment from the 5' region of the mouse neuronal c-SRC coding region was synthesized by the Polymerase Chain Reaction (PCR) from plasmid PVN 1.8. The fragment was inserted in the antisense orientation into plasmid pOPI3CAT, generating plasmid pOPI3-CRS, in which the SRC antisense sequence was transcribed under control of the bacterial lac 
Transfections
Stable transfections were by electroporation. One pulse of 250 volts, capacitance ± 960 mFarad was applied to 2.5610 6 cells in a Bio-Rad 0.4 cm cuvette. DHER14 cells were transfected with plasmid pOP3'SS, which leads to constitutive expression of Lac repressor. Following electroporation cells were plated on 10 cm culture dishes and grown in medium containing hygromycin (300 mg/ml; Boehringer Mannheim). Ten hygromycin-resistant clones were isolated for each cell type. The clones were probed with polyclonal anti Lac repressor antibody (Stratagene). Clones which were found to express high levels of the Lac repressor were chosen for transfection with the antisense expression plasmid pOPI3-CRS. After transfection with plasmid pOPI3-CRS, cells were plated on 10 cm culture dishes and grown in a double selection medium containing 300 mg/ml hygromycin and 400 mg/ml G-418 (GIBCO-BRL). Plasmid pNRTIS-CRS was transfected into CSH12 cells by electroporation as described above. The selective medium contained G-418 (400 mg/ml) and doxicyclin (100 ng/ml Sigma). In transient transfections cells were transfected with Fugene 6 (Boehringer Mannheim) according to the manufacturer's instructions. Cells were seeded at 7610 4 cells/well in a 6 well plate 24 h prior to transfection. Total DNA for transfection was 2.5 mg per well including 1 mg of luciferase reporter constructs, 0.5 mg of b-galactosidase (b-gal) internal control vector and 1 mg of the speci®c construct, as indicated in results. The Bcl-X promoter-luciferase plasmids (pGL2-3.2, pGL2-0.6R) have been described (Grillot et al., 1997) . pUSE-WT-Src, pUSE-KD-Src and pUSE-activated-Src constructs were obtained from Upstate Biochemistry. c-SRC antisense was cotransfected with Lac-Z gene containing plasmid under the CMV promoter to DHER14 cells. Cells were seeded in 6 well plates (7610 4 cells/well). Twenty-four and 72 h after transfection cells were stained with X-Gal (GIBCO-BRL) (Sanes et al., 1986) , and blue cells were counted in ten dierent ®elds. The decline in blue cell number was taken as a measure of antisense (or BAD) induced cell death. We attributed the dierences in the numbers of blue cells at 24 h to dierences in transfection eciencies, because we assumed that cell death was minimal at that time. We therefore normalized the 72 h cell counts to the 24 h counts. If some cells had already died at 24 h, this would only heighten the signi®cance of the results.
Growth curves and cell staining
Cell growth was determined by the microculture methylene blue assay (Ben-Bassat et al., 1995) . Cells were ®xed in glutaraldehyde, 0.05% ®nal concentration, for 10 min at room temperature. After washing, the microplates were stained with 1% methylene blue in 0.1 M borate buer pH 8.5 for 60 min at room temperature. The plates were then washed extensively and rigorously to remove excess dye and dried. The dye taken up by cells was eluted in 0.1 N HCl for 60 min at 378C, and absorbance monitored at 650 nm. Each point of the growth curve experiments was calculated from 6 ± 8 wells. The cells were photographed after ®xation and methylene blue staining as described.
Immunoblotting
Cells were washed three times with PBS, then lyzed with sample buer (10% glycerol, 0.2 M Tris pH 6.8, 5% bmercaptoethanol, 3% SDS) and boiled for 5 min. The whole cell lysate was then subjected to SDS ± PAGE and transferred to nitrocellulose. The membranes were blocked in TBST (10 mM Tris HCl pH 7.5, 50 mM NaCl and 0.1% Triton X-100) containing 5% low fat (1%) milk for 30 min. Membranes were then incubated for 1.5 h with primary antibody (indicated in Figure legends ). Membranes were washed extensively with TBST and immunoreactive proteins were detected by incubation with horseradish peroxidaseconjugated anti-mouse IgG (Jackson Immuno Research 1 : 10 000) for detection of monoclonal antibodies or horseradish peroxidase-conjugated anti-rabbit IgG (Jackson Immuno Research 1 : 10 000) for detection of polyclonal antibodies. Proteins were visualized using enhanced chemiluminescence (ECL).
Soft agar assay
Each well of a 6-well culture dish was coated with 2 ml bottom agar mixture (DMEM, 10% FCS or CS, 1% agar). After the bottom layer had solidi®ed, 2 ml top agar mixture (DMEM, 10% FCS or CS, 0.3% agar) containing the cells were added. After this layer had solidi®ed, the protein tyrosine inhibitors (at concentrations indicated in ®gure legends) or IPTG were overlaid in an additional 2 ml of medium (DMEM, 10% FCS or CS). IPTG was used at a ®nal concentration of 5 mM. Plates were incubated at 378C. On day 10, colonies from 10 ± 20 dierent ®elds were counted and the average number of colonies per well was calculated. The wells were overlaid with 2 ml MTT (1 mg/ml), incubated for an additional 4 h in 378C, and then photographed under light microscope magni®cation 6100.
Apoptosis assays
For FACS analysis, cells were seeded on 90 mm dishes and treated with PP1 for 24 and 48 h. Cells in medium and adherent cells were collected after trypsinization, and stained with Annexin-V-FLOUS+PI according to the manufacturer's instructions (Boehringer Mannheim). For DNA fragmentation analysis, cells were ®xed with 70% ethanol for 1 h on ice, and then incubated with PI solution (50 mg/ml PI, 0.1% sodium citrate, 0.1% Triton X-100, 100 mg/ml RNAse A, in PBS). For¯uorescent microscopy, cells were grown on 6-well plates and treated as written above. Cells were stained with Annexin-PI and photographed under MRC-1024 confocal microscope (BioRad). The photographs show FITC (525/40 nm) and PI (655/90 nm) channels together.
Src inhibitor
PP1 (Hanke et al., 1996) , was synthesized as described (Schindler et al., 1999) .
